Subscribe To

Price Alert Latest News Economic Calendar News

AFYA / Afya Limited (AFYA) Q2 2023 Earnings Call Transcript

Afya Limited (NASDAQ:AFYA ) Q2 2023 Earnings Conference Call August 28, 2023 5:00 PM ET Company Participants Renata Couto - Investor Relations Executive Manger Virgilio Gibbon - Chief Executive Officer Luis André Blanco - Chief Financial Officer Conference Call Participants Lucca Marquezini - Itaú BBA Lucas Nagano - Morgan Stanley Jessica Mehler - JPMorgan Mauricio Cepeda - Credit Suisse Renata Couto Thank you for joining us for Afya's Second Quarter 2023 Conference Call. Today I'm here with Afya's CEO, Virgilio Gibbon; and Luis André Blanco, our CFO. Read More

Demo Live Account See Partner Details

Content Topics

AFYA

Limited

2023

Earnings

Call

Transcript

afya

Stock

Posted: Aug 28 2023, 20:36

Author Name: Seeking Alpha

AFYA News

By Zacks Investment Research
October 31, 2023

Afya (AFYA) Stock Drops Despite Market Gains: Important Facts to Note

Afya (AFYA) concluded the recent trading session at $16.10, signifying a -0.86% move from its prior day's close.

By Zacks Investment Research
October 25, 2023

Afya (AFYA) Advances While Market Declines: Some Information for Investors

In the latest trading session, Afya (AFYA) closed at $16.01, marking a +1.01% move from the previous day.

By Zacks Investment Research
October 12, 2023

Afya (AFYA) Suffers a Larger Drop Than the General Market: Key Insights

In the most recent trading session, Afya (AFYA) closed at $15.43, indicating a -1.03% shift from the previous trading day.

By Business Wire
October 2, 2023

Afya Limited to Report Third Quarter and Nine Months 2023 Financial Results on November 13th

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited, or “Afya” (Nasdaq: AFYA, B3: A2FY34) announced today that will report third-quarter and nine mon

By Seeking Alpha
August 28, 2023

Afya Limited (AFYA) Q2 2023 Earnings Call Transcript

Afya Limited (NASDAQ:AFYA ) Q2 2023 Earnings Conference Call August 28, 2023 5:00 PM ET Company Participants Renata Couto - Investor Relations Executi

By Zacks Investment Research
August 28, 2023

Afya (AFYA) Q2 Earnings Lag Estimates

Afya (AFYA) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of

By Seeking Alpha
August 24, 2023

Afya: Asymmetric Bet On The Solid Brazilian Demography And A Great Business

Brazil is well positioned to capitalize on the upcoming commodities super cycle. Combined with the solid demography, this will create a higher demand

By Zacks Investment Research
August 16, 2023

Are Investors Undervaluing Afya (AFYA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.